The Second Workshop on Extreme Precision Radial Velocities defined circa 2015 the state
of the art Doppler precision and identified the critical path challenges for reaching 10 cm s− 1 …

Tisagenlecleucel (CTL019) is an investigational immunotherapy that involves reprogramming
a patient’s own T cells with a transgene encoding a chimeric antigen receptor to identify …

Structural variants (SVs) can contribute to oncogenesis through a variety of mechanisms.
Despite their importance, the identification of SVs in cancer genomes remains challenging. …

Purpose: Ribociclib (an oral, highly specific cyclin-dependent kinase 4/6 inhibitor) inhibits
tumor growth in preclinical models with intact retinoblastoma protein (Rb + ). This first-in-…

In response to the COVID-19 pandemic, governments have implemented a wide range of
non-pharmaceutical interventions (NPIs). Monitoring and documenting government strategies …

Coronavirus outbreak has affected thousands of people in at least 186 countries which has
affected the cancer care delivery system apart from affecting the overall health system. …

Interferon therapies suffer from a relatively short half-life of the products in circulation. To
address this issue we investigated the effects of polyethylene glycol modification (PEGylation) …

The development of a time-resolved coherent anti-Stokes Raman scattering (CARS) variant
for use as a probe of excited electronic state Raman-active modes following excitation with …

Purpose: Tisagenlecleucel is an anti-CD19 chimeric antigen receptor (CAR19) T-cell therapy
approved for the treatment of children and young adults with relapsed/refractory (r/r) B-cell …

Canakinumab is a high-affinity human monoclonal anti-interleukin-1β (IL-1β) antibody of the
IgG1/κ isotype designed to bind and neutralize the activity of human IL-1β, a pro-…